InvestorsHub Logo
icon url

Anshu2

12/13/22 12:43 PM

#392126 RE: Investor2014 #392124

Maybe, CM did meet with FDA and fda said to file nda after excellence.
icon url

WolfofMia

12/13/22 12:47 PM

#392128 RE: Investor2014 #392124

In agreement, but dont you think the TGD has bigger fish to fry now days?

Not saying one thing can stop the other, but even if expanded assess is being work on behind closed doors.

Is it worth the announcement now? Is that really what the market is in search for or what we should focus our limited resources on?

Maybe it was even dropped from the company's top priorities at the moment.

Not sure but seems logical to do so in my opinion.

Top priorities (for me): AD full data, Rett completion (Excellence), PDD Extensions data, PD trial initiation.

Re-using post: I know is from February is it not possible the FDA guided the same for expanded. Wait for Excellence for more safety data on Rett, just a guess to why not thus far.
icon url

sab63090

12/13/22 2:21 PM

#392157 RE: Investor2014 #392124

These two guys are playing tag-team, but you have the better memory and FACTS....